Charles Potter presented at the Management Forum’s Injectable Drug Delivery conference on the 24-25 March 2011.
His presentation 'Why Inject Liquids – A Review of the Benefits and Options for Injecting Drugs and Vaccines in a Solid Dosage Form' outlined, the latest Glide technology developments, emphasising the advantages for patients, healthcare workers and pharmaceutical companies for adopting a solid dose injection system including: Drug stability, Controlled release, Reduced frequency of injections, Delivery of poorly soluble drugs, Ease of use, Safety, Compliance, Product differentiation, Life cycle management / patent extension and Low cost of goods.
